The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Lauren - 1st May 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Lauren is from the UK, and uses low dose naltrexone (LDN) for chronic fatigue syndrome (CFS), myalgic encephalomyelitis (ME), fibromyalgia, and Ehlers-Danlos syndromes (EDS).
Dr John Kim, MD - 7th November 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'd like to welcome back Dr John Kim, who I know many of you have listened to his radio shows in the past. He's always got exciting things to tell us. So welcome, John and thank you for joining us today.
Erin's experience of Low Dose Naltrexone (LDN) for Hypopituitary or Secondary adrenal insufficiency, Hashimoto's Thyroiditis, Lupus and Depression.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.